Montefiori LE, Iacobucci I, Gao Q, Moore J, et al. Venetoclax plus gilteritinib is effective in preclinical models of FLT3-mutant BCL11B-a lineage-ambiguous leukemia. Blood 2025 Aug 14:blood.2025028985. doi: 10.1182/blood.2025028985.
PMID: 40811853